EUROLAB
iso-10993-23-assessment-of-toxicity
Chemical Resistance and Material Compatibility Testing ASTM D130 Copper Corrosion TestingASTM D130 Corrosion Testing of MetalsASTM D2240 Hardness Testing of Polymer MaterialsASTM D2240 Hardness Testing Post Chemical ExposureASTM D256 Impact Resistance After Chemical ExposureASTM D257 Electrical Resistivity Post Chemical ExposureASTM D2765 Thermal Analysis After Chemical ExposureASTM D3359 Adhesion of Coatings Post Chemical ExposureASTM D3359 Adhesion Testing After Chemical ExposureASTM D3762 Abrasion Resistance Post Chemical ExposureASTM D3985 Oxygen Transmission Rate After Chemical ExposureASTM D4216 Chemical Resistance of PolypropyleneASTM D471 Swelling Resistance in LiquidsASTM D4727 Resistance of Rubber to ChemicalsASTM D522 Flexibility Post Chemical ExposureASTM D543 Chemical Resistance of PlasticsASTM D543 Resistance of Plastics to Chemical ReagentsASTM D543-14 Chemical Resistance of Plastics and ElastomersASTM D570 Water Absorption of PlasticsASTM D570 Water Absorption of Polymer SamplesASTM D638 Tensile Properties After Chemical TreatmentASTM D638 Tensile Testing of Chemical-Exposed SamplesASTM D638 Tensile Testing Post Chemical ExposureASTM D648 Heat Deflection Temperature After Chemical ExposureASTM D7338 Chemical Resistance of PolyethyleneASTM D746 Low Temperature Impact Post Chemical ExposureASTM D7569 Resistance to Chemical ExposureASTM D792 Density of Plastics After Chemical ExposureASTM D882 Tensile Properties of Thin Plastic SheetingASTM E96 Water Vapor Transmission Post Chemical ExposureASTM F1515 Chemical Resistance of Medical PlasticsASTM F1522 Resistance to Chemicals in Medical DevicesASTM F1874 Chemical Resistance of ElastomersASTM F2026 Chemical Resistance of Polymeric MaterialsASTM F2028 Chemical Compatibility of Surgical InstrumentsASTM F2033 Chemical Resistance of Medical PolymersASTM F2299 Resistance to Bacterial PenetrationASTM F2397 Chemical Resistance of ElastomersASTM F739 Chemical Permeation TestingASTM F748 Resistance of Polymers to ChemicalsASTM F903 Liquid Penetration ResistanceASTM F904 Chemical Resistance of Polymers in Medical UseISO 10993-1 Biological Evaluation ProcessISO 10993-10 Biological Evaluation of MaterialsISO 10993-10 Irritation Testing Post Chemical ExposureISO 10993-11 Cytotoxicity Testing Post Chemical ExposureISO 10993-12 Chemical Resistance Sample PreparationISO 10993-13 Extraction Methods for Medical DevicesISO 10993-14 Degradation Products in Medical MaterialsISO 10993-15 Identification of Degradation ProductsISO 10993-16 Toxicokinetics of MaterialsISO 10993-17 Toxicological Risk AssessmentISO 10993-18 Chemical Characterization of Medical DevicesISO 10993-19 Chemical Characterization for Medical DevicesISO 10993-2 Animal Welfare Requirements in TestingISO 10993-20 Sensitization TestingISO 10993-21 Evaluation of Degradation ProductsISO 10993-22 Evaluation of Material InteractionISO 10993-24 Evaluation of Extractables and LeachablesISO 10993-25 Material Compatibility ValidationISO 10993-26 Chronic Toxicity TestingISO 10993-27 Immunotoxicology TestingISO 10993-28 Mutagenicity TestingISO 10993-29 Chemical Residue LimitsISO 10993-3 Genotoxicity Testing of Medical MaterialsISO 10993-30 Toxicological Risk AssessmentISO 10993-4 Blood Compatibility TestingISO 10993-4 Hemocompatibility TestingISO 10993-5 In Vitro CytotoxicityISO 10993-6 Local Effects after Chemical ExposureISO 10993-7 Ethylene Oxide Residue LimitsISO 10993-8 Material Compatibility with BloodISO 10993-9 Selection of Tests for Medical MaterialsISO 11135 Material Compatibility in EO SterilizationISO 11135-1 EO Sterilization Material CompatibilityISO 11135-2 EO Sterilization Effects on MaterialsISO 11137 Chemical Resistance of Sterilized DevicesISO 11607 Material Compatibility with SterilizationISO 13485 Material Compatibility RequirementsISO 14644-1 Cleanroom Material CompatibilityISO 14644-3 Cleanroom Material CompatibilityISO 22442 Compatibility of Implants with Biological SystemsISO 22442-2 Biocompatibility TestingISO 22442-3 Evaluation of Material Safety

Comprehensive Guide to ISO 10993-23 Assessment of Toxicity Laboratory Testing Service

Provided by Eurolab

ISO 10993-23 is a standard that outlines the requirements for assessing the toxicity of materials and products used in medical devices. The standard is part of the larger ISO 10993 series, which provides guidelines for evaluating the biological safety of medical devices.

International Standards Governing ISO 10993-23 Assessment of Toxicity

  • ISO 10993-1:2018 - Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process

  • ISO 10993-2:1994 - Biological evaluation of medical devices Part 2: Test methods for in vitro cytotoxicity

  • EN ISO 10993-12:2013 - Biological evaluation of medical devices Part 12: Sample preparation and reference materials

  • ASTM F748 - 17 - Standard Practice for Selecting Generic Biological Tests for Materials and Devices

    • Legal and Regulatory Framework Surrounding this Testing Service

    The legal and regulatory framework surrounding ISO 10993-23 Assessment of Toxicity testing is governed by various international, national, and regional regulations. Some key regulations include:

  • EU Medical Device Regulation (MDR) 2017/745

  • US FDAs 21 CFR Part 809: In Vitro Diagnostic Devices

  • ISO 13485:2016 - Medical devices Quality management systems Requirements for regulatory purposes

    • Standard Development Organizations and their Role

    Standard development organizations play a crucial role in the development of standards governing medical device safety. Some key standard development organizations include:

  • International Organization for Standardization (ISO)

  • American Society for Testing and Materials (ASTM)

  • European Committee for Standardization (CEN)

    • How Standards Evolve and Get Updated

    Standards evolve and get updated through a continuous process of review, revision, and implementation. This process involves input from various stakeholders, including industry experts, regulatory bodies, and standard development organizations.

    Specific Standard Numbers and their Scope

    The following are some specific standard numbers and their scope:

  • ISO 10993-23:2019 - Biological evaluation of medical devices Part 23: Tests for cytotoxicity in vitro

  • EN ISO 10993-23:2006 - Biological evaluation of medical devices Part 23: Tests for cytotoxicity in vitro

    • Standard Compliance Requirements for Different Industries

    Standard compliance requirements vary depending on the industry and regulatory framework. For example:

  • Medical device manufacturers must comply with EU MDR 2017/745 and US FDAs 21 CFR Part 809.

  • In-vitro diagnostic devices must comply with ISO 13485:2016.

    • ISO 10993-23 Assessment of Toxicity testing is essential for ensuring the safety and efficacy of medical devices. This test assesses the cytotoxicity of materials used in medical devices, which can help prevent adverse reactions and ensure patient safety.

    Business and Technical Reasons for Conducting ISO 10993-23 Assessment of Toxicity Testing

    The business and technical reasons for conducting ISO 10993-23 Assessment of Toxicity testing include:

  • Ensuring product safety and efficacy

  • Complying with regulatory requirements

  • Meeting customer expectations

  • Reducing liability risks

    • Consequences of Not Performing this Test

    Not performing ISO 10993-23 Assessment of Toxicity testing can have severe consequences, including:

  • Regulatory non-compliance

  • Product recalls and withdrawals

  • Financial losses and reputational damage

  • Patient safety risks

    • Industries and Sectors that Require this Testing

    The following industries and sectors require ISO 10993-23 Assessment of Toxicity testing:

  • Medical device manufacturers

  • In-vitro diagnostic device manufacturers

  • Pharmaceutical companies

  • Biotechnology companies

    • Risk Factors and Safety Implications

    Risk factors and safety implications associated with medical devices include:

  • Adverse reactions and toxicity

  • Device malfunction and failure

  • Patient injury and death

    • Quality Assurance and Quality Control Aspects

    Quality assurance and quality control aspects of ISO 10993-23 Assessment of Toxicity testing include:

  • Equipment calibration and maintenance

  • Sample preparation and handling

  • Testing parameters and conditions

  • Data collection and recording

    • ISO 10993-23 Assessment of Toxicity testing involves the following steps:

    Step-by-Step Explanation of How the Test is Conducted

    1. Sample Preparation: Prepare the test samples according to the standard requirements.

    2. Testing Equipment and Instruments: Use calibrated and maintained equipment, such as cell culture plates and spectrophotometers.

    3. Testing Environment Requirements: Maintain a controlled environment with specific temperature, humidity, and lighting conditions.

    4. Testing Parameters and Conditions: Follow the standard guidelines for testing parameters and conditions, including incubation time, temperature, and pH levels.

    5. Data Collection and Recording: Record and analyze data according to the standard requirements.

    Testing Parameters and Conditions

    The following are some key testing parameters and conditions:

  • Cell culture medium and cell types

  • Incubation time and temperature

  • pH levels and osmolality

  • Spectrophotometry and other analytical techniques

    • Equipment Calibration and Maintenance

    Equipment calibration and maintenance are crucial for ensuring the accuracy and reliability of test results. This includes:

  • Regular calibration of equipment, such as spectrophotometers and cell culture plates

  • Maintenance of equipment, including cleaning and replacement of consumables

    • ISO 10993-23 Assessment of Toxicity testing provides valuable information on the cytotoxicity of materials used in medical devices. Test results can help identify potential risks and ensure product safety.

    Key Factors Affecting Test Results

    The following are some key factors affecting test results:

  • Sample preparation and handling

  • Equipment calibration and maintenance

  • Testing parameters and conditions

  • Data collection and recording

    • Limitations of ISO 10993-23 Assessment of Toxicity Testing

    ISO 10993-23 Assessment of Toxicity testing has several limitations, including:

  • Limited in vitro relevance to human tissues and organs

  • Variability in test results due to differences in sample preparation and handling

  • Dependence on equipment calibration and maintenance for accurate results

    • ISO 10993-23 Assessment of Toxicity testing is a critical step in ensuring the safety and efficacy of medical devices. By understanding the standard requirements, test conditions, and methodology, manufacturers can ensure compliance with regulatory requirements and meet customer expectations.

    Future Directions for ISO 10993-23 Assessment of Toxicity Testing

    Future directions for ISO 10993-23 Assessment of Toxicity testing include:

  • Development of new testing methods and techniques

  • Improvement of standard guidelines and protocols

  • Increased use of in vitro testing for medical device development

    • Need help or have a question?
    Contact us for prompt assistance and solutions.

    CONTACT US +902127020000

    Latest News

    View all

    Eurolab Successfully Renews ISO 17025 Accreditation

    Read More

    Expanded Cosmetic Safety Testing Portfolio Now Available at Eurolab

    Read More

    Eurolab Launches Technical Training Series for Industry Professionals

    Read More

    JOIN US
    Want to make a difference?

    Careers